Yu, Ming-Lung <br/><br/>
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jun 2013 
 - 2135-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.26266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Carcinoma, Hepatocellular--virology<br/>Coinfection--complications<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Hepatitis B--complications<br/>Hepatitis B virus--genetics<br/>Hepatitis C--complications<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Liver Neoplasms--virology<br/>Male<br/>Middle Aged<br/>Mutation<br/>Polyethylene Glycols--therapeutic use<br/>Promoter Regions, Genetic<br/>Recombinant Proteins--therapeutic use<br/>Recurrence<br/>Ribavirin--therapeutic use<br/>Treatment Outcome<br/>Viral Core Proteins--genetics